EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan

Aasakiran Madamanchi, Michelle Ingle, Andrew P Hinck, David M Umulis

Biophysical Journal · 2023

DOI: 10.1016/j.bpj.2023.02.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysical Journal, 2023. Verfasst von Aasakiran Madamanchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, Indiana. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Transforming Growth Factor beta. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transforming growth factor-β1, -β2, and -β3 (TGF-β1, -β2, and -β3) are secreted signaling ligands that play essential roles in tissue development, tissue maintenance, immune response, and wound healing. TGF-β ligands form homodimers and signal by assembling a heterotetrameric receptor complex comprised of two type I receptor (TβRI):type II receptor (TβRII) pairs. TGF-β1 and TGF-β3 ligands signal with high potency due to their high affinity for TβRII, which engenders high-affinity binding of TβRI through a composite TGF-β:TβRII binding interface. However, TGF-β2 binds TβRII 200-500 more weakly than TGF-β1 and TGF-β3 and signals with lower potency compared with these ligands. Remarkably, the presence of an additional membrane-bound coreceptor, known as betaglycan, increases TGF-β2 signaling potency to levels similar to TGF-β1 and -β3. The mediating effect of betaglycan occurs even though it is displaced from and not present in the heterotetrameric receptor complex through which TGF-β2 signals. Published biophysics studies have experimentally established the kinetic rates of the individual ligand-receptor and receptor-receptor interactions that initiate heterotetrameric receptor complex assembly and signaling in the TGF-β system; however, current experimental approaches are not able to directly measure kinetic rates for the intermediate and latter steps of assembly. To characterize these steps in the TGF-β system and determine the mechanism of betaglycan in the potentiation of TGF-β2 signaling, we developed deterministic computational models with different modes of betaglycan binding and varying cooperativity between receptor subtypes. The models identified conditions for selective enhancement of TGF-β2 signaling. The models provide support for additional receptor binding cooperativity that has been hypothesized but not evaluated in the literature. The models further showed that betaglycan binding to the TGF-β2 ligand through two domains provides an effective mechanism for transfer to the signaling receptors that has been tuned to efficiently promote assembly of the TGF-β2(TβRII)2(TβRI)2 signaling complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1Transforming Growth Factor betaTransforming Growth Factor beta2Transforming Growth Factor beta3LigandsProtein Serine-Threonine KinasesComputer SimulationProteoglycansReceptors, Transforming Growth Factor beta

Substanzen

Transforming Growth Factor beta1Transforming Growth Factor betaTransforming Growth Factor beta2Transforming Growth Factor beta3LigandsProtein Serine-Threonine KinasesbetaglycanProteoglycansReceptors, Transforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, Indiana.
  • Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, Indiana; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana. Electronic address: dumulis@purdue.…

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Madamanchi, A., Ingle, M., Hinck, A. P., & Umulis, D. M. (2023). Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan. Biophysical Journal. https://doi.org/10.1016/j.bpj.2023.02.030

Vancouver

Madamanchi A, Ingle M, Hinck AP, Umulis DM. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan. Biophysical Journal. 2023. doi:10.1016/j.bpj.2023.02.030

BibTeX
@article{Madamanchi2023,
  author = {Madamanchi, Aasakiran and Ingle, Michelle and Hinck, Andrew P and Umulis, David M},
  title = {Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan},
  journal = {Biophysical Journal},
  year = {2023},
  doi = {10.1016/j.bpj.2023.02.030}
}
Kostenlos starten →